These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35370617)

  • 1. COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study.
    Guo P; Benito Ballesteros A; Yeung SP; Liu R; Saha A; Curtis L; Kaser M; Haggard MP; Cheke LG
    Front Aging Neurosci; 2022; 14():804922. PubMed ID: 35370617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study.
    Guo P; Benito Ballesteros A; Yeung SP; Liu R; Saha A; Curtis L; Kaser M; Haggard MP; Cheke LG
    Front Aging Neurosci; 2022; 14():804937. PubMed ID: 35370620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 severity is related to poor executive function in people with post-COVID conditions.
    Ariza M; Cano N; Segura B; Adan A; Bargalló N; Caldú X; Campabadal A; Jurado MA; Mataró M; Pueyo R; Sala-Llonch R; Barrué C; Bejar J; Cortés CU; ; Garolera M; Junqué C
    J Neurol; 2023 May; 270(5):2392-2408. PubMed ID: 36939932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reported neurological symptoms after severe acute respiratory syndrome coronavirus type 2 infection: A systematic diagnostic approach.
    Ludwig B; Deckert M; Krajnc N; Keritam O; Macher S; Bsteh G; Zulehner G; Thurnher M; Berger T; Seidel S; Willinger U; Rommer P
    Eur J Neurol; 2023 Sep; 30(9):2713-2725. PubMed ID: 37306533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and impact of Long Covid: Findings from an online survey.
    Ziauddeen N; Gurdasani D; O'Hara ME; Hastie C; Roderick P; Yao G; Alwan NA
    PLoS One; 2022; 17(3):e0264331. PubMed ID: 35259179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study.
    Widmann CN; Wieberneit M; Bieler L; Bernsen S; Gräfenkämper R; Brosseron F; Schmeel C; Tacik P; Skowasch D; Radbruch A; Heneka MT
    JMIR Res Protoc; 2021 Nov; 10(11):e30259. PubMed ID: 34559059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social Distance in COVID-19: Drawing the line between protective behavior and stigma manifestation.
    Economou M
    Psychiatriki; 2021 Sep; 32(3):183-186. PubMed ID: 34390552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
    Ermis U; Rust MI; Bungenberg J; Costa A; Dreher M; Balfanz P; Marx G; Wiesmann M; Reetz K; Tauber SC; Schulz JB
    Neurol Res Pract; 2021 Mar; 3(1):17. PubMed ID: 33712089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
    J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.
    Gupta D; Sharma R; Patwardhan B; Mathur RD
    J Assoc Physicians India; 2021 Sep; 69(9):11-12. PubMed ID: 34585882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19.
    Krishnan K; Miller AK; Reiter K; Bonner-Jackson A
    Arch Clin Neuropsychol; 2022 May; 37(4):729-737. PubMed ID: 35136912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    medRxiv; 2020 Oct; ():. PubMed ID: 33106813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
    de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
    JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis.
    Ceban F; Ling S; Lui LMW; Lee Y; Gill H; Teopiz KM; Rodrigues NB; Subramaniapillai M; Di Vincenzo JD; Cao B; Lin K; Mansur RB; Ho RC; Rosenblat JD; Miskowiak KW; Vinberg M; Maletic V; McIntyre RS
    Brain Behav Immun; 2022 Mar; 101():93-135. PubMed ID: 34973396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.